Dewhirst Lab

Publications

  1. Jones LW, Antonelli J, Masko EM, Boardwater G, Lascola CD, Fels D, DEWHIRST MW, Dyck JR, Nagendran J, Flores CT, Betof AS, Nelson ER, Pollak M, Dash RC, Young ME, Freedland SJ.  Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer.  J Appl Physiol.  2012 Jul; 113(2): 263-72.  PMID:  22604887.  PMCID:  PMC3404704. 

  2.  Sonveaux P, Copetti T, De Saedeleer CJ, Vegran F, Verrax J, Kennedy KM, Moon EJ, Dhup S, Danhier P, Frerart F, Gallez B, Ribeiro A, Michiels C, DEWHIRST MW, Feron O.  Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis.  PLoS One.  2012;7(3):e33418.  PMID:  22428047.  PMCID:  PMC3302812.

  3.  Palmer GM, Fontanella AN, Shan S, DEWHIRST MW. High-resolution in vivo imaging of fluorescent proteins using window chamber models. Methods Mol Biol. 872:31-50, 2012. (Book chapter).

  4.  Betof AS, Rabbani ZN, Hardee ME, Kim SJ, Broadwater G, Bentley RC, Snyder SA, Vujaskovic Z, Oosterwijk E, Harris LN, Horton JK, DEWHIRST MW, Blackwell KL. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification. Br J Cancer. 106(5):916-22, 2012. PMCID: PMC3305967.
  5. Betof AS, DEWHIRST MW, Jones LW. Effects and potential mechanisms of exercise training on cancer progression: A translational perspective. Brain Behav Immun. 2012.  NIHMSID: NIHMS438332.

  6. Salahi S, Maccarini PF, Rodrigues DB, Etienne W, Landon CD, Inman BA, DEWHIRST MW, Stauffer PR. Miniature microwave applicator for murine bladder hyperthermia studies.  Int J Hypterthermia.  2012; 28 (5):  456-65.  PMID:  22690856.  PMCID:  PMC3399990.

  7. Klink JC, Tewari AK, Masko EM, Antonelli J, Febbo PG, Cohen P, DEWHIRST MW, Pizzo SV, Freedland SJ.  Reservatrol Worsens Survival in SCID Mice with Prostate Cancer Xenografts in a Cell-Line Specific Manner, Through Paradoxical Effects on Oncogenic Pathways.  The Prostate. DOI 10.1002/pros 22619.  2012; 10 (17).  PMID:  23192356.  PubMed In Process.

  8. Thrall DE, Maccarini P, Stauffer P, Macfall J, Hauck M, Snyder S, Case B, Linder K, Lan L, McCall L, DEWHIRST  MW.  Thermal dose fractionation affects tumor physiological response.  Int J Hyperthermia.  2012; 28(5):  431-40.  PMID:  22804741.  Pub Med:  In Process.

  9. Manzoor AA, Lindner LH, Landon CD, Park JY, Simnick AJ, Dreher MR, Das S, Hanna G, Park W, Chilkoti A, Koning GA, ten Hagen TL, Needham D, DEWHIRST MW.  Overcoming limitations in nanoparticle drug delivery:  triggered, intravascular release to improve drug penetration into tumors.  Cancer Res.  2012 Nov 1; 72(21): 5566-75.  PMID:  22952218.  PMCID: PMC3517817.

  10. Chitneni SK, Bida GT, DEWHIRST MW, Zalutsky MR. A simplified synthesis of the hypoxia imaging agent  2- (2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18) F]pentafluoropropyl)-acetamide ([18F]EF5).  Nucl Med Biol. 39(7):1012-8, 2012. PMCID: PMC3478693

  11. Beasley GM, Sharma K, Wong J, Miller M, Turley RS, Lidsky M, Masoud M, DEWHIRST MW, Mosca PJ, Zager JS, Tyler DS.  A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.  Cancer.  2012 Dec 15; 118(24): 6136- 43.  PMID:  22674423.  PubMed – In Process.